SCHEMBL7226471

SCHEMBL7226471

CCCN(CCC)C(=O)c1ccc2c(c1)C(=C(C)Nc1ccc(Cl)cc1)C(=O)N2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.42
KDR P35968 4/20 0.41
TLR8 Q9NR97 1/20 0.41
IDO1 P14902 2/20 0.40
TDO2 P48775 2/20 0.40
EGFR P00533 2/20 0.40
INSR P06213 1/20 0.40
IGF1R P08069 1/20 0.40
PDGFRB P09619 1/20 0.40
KIT P10721 1/20 0.40
FGFR1 P11362 1/20 0.40
SRC P12931 1/20 0.40
PDGFRA P16234 1/20 0.40
FLT1 P17948 1/20 0.40
EPHA2 P29317 1/20 0.40
FLT4 P35916 1/20 0.40
FLT3 P36888 1/20 0.40
RPS6KA3 P51812 1/20 0.40
EPHB4 P54760 1/20 0.40
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7226468 1.00 LRRK2 (0.42) LRRK2KDRTLR8IDO1TDO2
SCHEMBL7231499 0.92 GRM5 (0.46) LRRK2KDRIDO1TDO2EGFR
SCHEMBL7231492 0.92 GRM5 (0.46) LRRK2KDRIDO1TDO2EGFR
SCHEMBL6980882 0.89 TLR8 (0.40) LRRK2KDRTLR8EGFRINSR
SCHEMBL7987912 0.89 TLR8 (0.40) LRRK2KDRTLR8EGFRINSR
SCHEMBL7234212 0.87 ALDH1A1 (0.39) LRRK2TLR8PDPK1AKT2AKT1
SCHEMBL7234207 0.87 ALDH1A1 (0.39) LRRK2TLR8PDPK1AKT2AKT1
SCHEMBL7225500 0.86 LRRK2 (0.46) LRRK2KDRIDO1TDO2RAB9A
SCHEMBL7225498 0.86 LRRK2 (0.46) LRRK2KDRIDO1TDO2RAB9A
SCHEMBL7233848 0.84 ALDH1A1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545035-B1 Having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-04-08 US disclosed
US-6319918-B1 FOR LYMPHOMA OR SOLID TUMORS TREATMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-20 US disclosed
EP-1100779-A1 SUBSTITUTED INDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim Pharma KG (DE) 2001-05-23 EP disclosed
WO-1999062882-A1 SUBSTITUTED INDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-09 WO disclosed